VR Logo

IVERIC bio Inc. (ISEE) download report


Healthcare | Biotechnology & Pharma Research

IVERIC bio Inc. (ISEE) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs).

IPO Date: 25-Sep-2013

CEO & Director: Mr. Glenn P. Sblendorio M.B.A.

Pres: Dr. Pravin U. Dugel M.D.

Listing: NASDAQ: ISEE

Country: United States

Headquarters: Parsippany, NJ

Website: https://ivericbio.com

Key Facts

Market cap: $1,114.13 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-122.26 Mln

Cash: $345.66 Mln

Total Debt: $1.34 Mln

Insider's Holding: 0.59%

Liquidity: Low

52 Week range: $5.96 - 19.35

Shares outstanding: 116,419,000

10 Years Aggregate:

  • CFO: $-514.80 Mln
  • EBITDA: $-673.80 Mln
  • Net Profit: $-543.67 Mln

Stock Performance

Time Period IVERIC bio (ISEE) S&P BSE Sensex S&P Small-Cap 600
YTD-37.56-9.49-17.79
1 month-5.61-2.87-2.72
3 months-35.24-8.59-12.17
1 Year78.160.81-15.82
3 Years99.7510.397.14
5 Years29.2011.116.20
10 Years--12.0010.33
As on 24-Jun-2022
Year IVERIC bio (ISEE) S&P Small-Cap 600 S&P BSE Sensex
2021141.9725.2721.99
2020-19.469.5715.75
2019615.0020.8614.38
2018-61.34-9.705.87
2017-35.4011.7327.91
2016-93.8524.741.95
201575.02-3.36-5.03